全文获取类型
收费全文 | 8033篇 |
免费 | 445篇 |
国内免费 | 64篇 |
专业分类
耳鼻咽喉 | 65篇 |
儿科学 | 227篇 |
妇产科学 | 193篇 |
基础医学 | 1166篇 |
口腔科学 | 196篇 |
临床医学 | 647篇 |
内科学 | 1851篇 |
皮肤病学 | 188篇 |
神经病学 | 935篇 |
特种医学 | 400篇 |
外科学 | 890篇 |
综合类 | 36篇 |
预防医学 | 389篇 |
眼科学 | 171篇 |
药学 | 526篇 |
中国医学 | 38篇 |
肿瘤学 | 624篇 |
出版年
2024年 | 13篇 |
2023年 | 83篇 |
2022年 | 149篇 |
2021年 | 234篇 |
2020年 | 136篇 |
2019年 | 187篇 |
2018年 | 243篇 |
2017年 | 179篇 |
2016年 | 194篇 |
2015年 | 233篇 |
2014年 | 287篇 |
2013年 | 362篇 |
2012年 | 555篇 |
2011年 | 578篇 |
2010年 | 351篇 |
2009年 | 332篇 |
2008年 | 512篇 |
2007年 | 535篇 |
2006年 | 548篇 |
2005年 | 493篇 |
2004年 | 491篇 |
2003年 | 471篇 |
2002年 | 409篇 |
2001年 | 92篇 |
2000年 | 75篇 |
1999年 | 97篇 |
1998年 | 88篇 |
1997年 | 73篇 |
1996年 | 56篇 |
1995年 | 44篇 |
1994年 | 30篇 |
1993年 | 36篇 |
1992年 | 29篇 |
1991年 | 27篇 |
1990年 | 26篇 |
1989年 | 34篇 |
1988年 | 34篇 |
1987年 | 25篇 |
1986年 | 26篇 |
1985年 | 11篇 |
1984年 | 18篇 |
1983年 | 20篇 |
1982年 | 17篇 |
1981年 | 10篇 |
1979年 | 13篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1974年 | 7篇 |
1970年 | 10篇 |
1967年 | 7篇 |
排序方式: 共有8542条查询结果,搜索用时 15 毫秒
101.
102.
Marco Sangermano Paolo Allia Paola Tiberto Gabriele Barrera Federica Bondioli Nicola Florini Massimo Messori 《Macromolecular chemistry and physics.》2013,214(4):508-516
Magnetite nanoparticles were prepared by a non‐hydrolytic sol–gel (NHSG) process in the presence of benzyl alcohol. The obtained magnetite suspensions were mixed with an aliphatic epoxy resin and the formulations were photo‐polymerized to achieve composite materials with magnetic properties. The prepared magnetite nanoparticles and epoxy composites were fully characterized in terms of their magnetic properties. 相似文献
103.
Angela De Rose Gabriele Mikolasch Mathias Kamp Achim Kraft Mathias Nowottnick 《RSC advances》2020,10(66):40215
Within this work, we demonstrate that an easy soldering process in combination with wet chemical coating is suitable to realize a strong and reliable solder interconnection of Al substrates, even at short soldering times <5 s in ambient air. The microstructure of solder joints on wet chemically treated aluminum foils is investigated. A single and double zincate pre-treatment are compared to activate the Al surface, followed by electroless Ni plating. The quality of the solderable Ni surface is characterized by contact angle measurements, yielding good wettability (<60°), which is also achieved after isothermally heating (250 °C) the Ni-coated Al foils for 100 min. The microstructure of the Sn62Pb36Ag2 solder joints is investigated by SEM and EDX of cross sections, directly after soldering as well as after isothermal aging at 85 °C. Under the used soldering conditions, with a soldering temperature at about 280 °C, diffusion zones <500 nm were identified. Nonetheless, high peel forces after soldering >5 N mm−1 show stable values under aging conditions of 85 °C for 1000 hours. This could be correlated to a mixed fracture pattern, promoting the high adhesion due to the absence of a dominant failure mechanism.High mechanical reliability of tin-based solder joints processed by joining copper and nickel-coated aluminium with short soldering times in ambient air. 相似文献
104.
105.
106.
Human papillomavirus‐related basaloid squamous cell carcinoma of the bladder associated with genital tract human papillomavirus infection 下载免费PDF全文
Alessandro Ginori Aurora Barone Rosa Santopietro Gabriele Barbanti Filippo Cecconi Sergio Antonio Tripodi 《International journal of urology》2015,22(2):222-225
Basaloid squamous cell carcinoma is a biologically aggressive neoplasm mainly found in the head and neck region. Recently, four cases of basaloid squamous cell carcinoma of the bladder have been reported, and three of them occurred in patients with neurogenic bladder, repeated catheterizations and human papillomavirus infection of the urinary tract. To the best of our knowledge, none of the patients affected by basaloid squamous cell carcinoma of the bladder described in the literature had documented genital involvement by human papillomavirus. Herein, we describe the case of a woman with neurogenic bladder affected by basaloid squamous cell carcinoma of the bladder and by a concomitant genital tract human papillomavirus infection. 相似文献
107.
108.
<正>The efficacy of platelet-rich plasma(PRP)to promote tissue regeneration has been largely confirmed in several clinical settings,such as in human maxillo-facial(Froum et al.,2002),heart(Vu et al.,2015)and orthopaedic surgery(Zhang and Wang,2010).Up to date,few studies are available regarding the topical use of platelet-rich plasma in models of 相似文献
109.
Muhammad Ahsan Javed Georg Beyer Nha Le Alessio Vinci Helen Wong Daniel Palmer Robert D. Morgan Angela Lamarca Richard A. Hubner Juan W. Valle Salma Alam Sumsur Chowdhury Yuk Ting Ma Livia Archibugi Gabriele Capurso Patrick Maisonneuve Albrecht Neesse Malin Sund Sebastian Krug 《Pancreatology》2019,19(1):97-104
Background
Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis. Gemcitabine is the standard chemotherapy for patients with metastatic pancreatic adenocarcinoma (MPA). Randomized clinical trials evaluating intensified chemotherapies including FOLFIRINOX and nab-paclitaxel plus gemcitabine (NAB+GEM) have shown improvement in survival. Here, we have evaluated the efficacy of intensified chemotherapy versus gemcitabine monotherapy in real-life settings across Europe.Methods
A retrospective multi-center study including 1056 MPA patients, between 2012 and 2015, from nine centers in UK, Germany, Italy, Hungary and the Swedish registry was performed. Follow-up was at least 12 months. Cox proportional Harzards regression was used for uni- and multivariable evaluation of prognostic factors.Results
Of 1056 MPA patients, 1030 (98.7%) were assessable for survival analysis. Gemcitabine monotherapy was the most commonly used regimen (41.3%), compared to FOLFIRINOX (n = 204, 19.3%), NAB+GEM (n = 81, 7.7%) and other gemcitabine- or 5-FU-based regimens (n = 335, 31.7%). The median overall survival (OS) was: FOLFIRINOX 9.9 months (95%CI 8.4–12.6), NAB+GEM 7.9 months (95%CI 6.2–10.0), other combinations 8.5 months (95%CI 7.7–9.3) and gemcitabine monotherapy 4.9 months (95%CI 4.4–5.6). Compared to gemcitabine monotherapy, any combination of chemotherapeutics improved the survival with no significant difference between the intensified regimens. Multivariable analysis showed an association between treatment center, male gender, inoperability at diagnosis and performance status (ECOG 1–3) with poor prognosis.Conclusion
Gemcitabine monotherapy was predominantly used in 2012–2015. Intensified chemotherapy improved OS in comparison to gemcitabine monotherapy. In real-life settings, the OS rates of different treatment approaches are lower than shown in randomized phase III trials. 相似文献110.
Gabriele?Donati Maria?Ilaria?Moretti Olga?Baraldi Alessandra?Spazzoli Irene?Capelli Giorgia?Comai Antonio?Marchetti Maria?Sarma Rita?Mancini Gaetano?La MannaEmail author 《BMC nephrology》2016,17(1):193